Quaglino P - Search Results

1

Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon?

Savoia P, Fava P, Caliendo V, Osella-Abate S, Ribero S, Quaglino P, Macripò G, Bernengo MG. Savoia P, et al. Among authors: quaglino p. J Eur Acad Dermatol Venereol. 2012 Feb;26(2):242-8. doi: 10.1111/j.1468-3083.2011.04055.x. Epub 2011 Apr 6. J Eur Acad Dermatol Venereol. 2012. PMID: 21466591

2

Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance.

Doveil GC, Fierro MT, Novelli M, Appino A, Bertero M, Quaglino P, Bernengo MG. Doveil GC, et al. Among authors: quaglino p. Dermatology. 1995;191(3):234-9. doi: 10.1159/000246551. Dermatology. 1995. PMID: 8534942

3

Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.

Novelli M, Savoia P, Fierro MT, Verrone A, Quaglino P, Bernengo MG. Novelli M, et al. Among authors: quaglino p. Br J Dermatol. 1996 Jun;134(6):1052-6. Br J Dermatol. 1996. PMID: 8763423

4

Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot study.

Bernengo MG, Doveil GC, Bertero M, Quaglino P, Fierro MT, Savoia P, Appino A, Colonna S. Bernengo MG, et al. Among authors: quaglino p. Melanoma Res. 1996 Jun;6(3):257-65. doi: 10.1097/00008390-199606000-00009. Melanoma Res. 1996. PMID: 8819129 Clinical Trial.

5

Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.

Fierro MT, Doveil GC, Quaglino P, Savoia P, Verrone A, Bernengo MG. Fierro MT, et al. Among authors: quaglino p. Dermatology. 1997;194(3):268-72. doi: 10.1159/000246116. Dermatology. 1997. PMID: 9187846

6

CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.

Savoia P, Fierro MT, Novelli M, Quaglino P, Verrone A, Geuna M, Bernengo MG. Savoia P, et al. Among authors: quaglino p. Br J Dermatol. 1997 Dec;137(6):966-71. Br J Dermatol. 1997. PMID: 9470917

7

Immunohistologic findings and adhesion molecule pattern in primary pure cutaneous Rosai-Dorfman disease with xanthomatous features.

Quaglino P, Tomasini C, Novelli M, Colonna S, Bernengo MG. Quaglino P, et al. Am J Dermatopathol. 1998 Aug;20(4):393-8. doi: 10.1097/00000372-199808000-00013. Am J Dermatopathol. 1998. PMID: 9700380

8

Multiple primary melanomas: analysis of 49 cases.

Savoia P, Quaglino P, Verrone A, Bernengo MG. Savoia P, et al. Among authors: quaglino p. Melanoma Res. 1998 Aug;8(4):361-6. doi: 10.1097/00008390-199808000-00010. Melanoma Res. 1998. PMID: 9764812 Review.

9

Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.

Bernengo MG, Quaglino P, Novelli M, Cappello N, Doveil GC, Lisa F, De Matteis A, Fierro MT, Appino A. Bernengo MG, et al. Among authors: quaglino p. Ann Oncol. 1998 Aug;9(8):857-63. doi: 10.1023/a:1008397323199. Ann Oncol. 1998. PMID: 9789608 Free article.

10

Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP.

Fierro MT, Quaglino P, Savoia P, Verrone A, Bernengo MG. Fierro MT, et al. Among authors: quaglino p. Leuk Lymphoma. 1998 Nov;31(5-6):583-8. doi: 10.3109/10428199809057618. Leuk Lymphoma. 1998. PMID: 9922049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters